SEC Form 4 · accession 0001144204-15-011491
KIORA PHARMACEUTICALS INC · KPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael P. Manzo
Officer — Vice President of Engineering
Period of report
Feb 19, 2015
Accepted (ET)
Feb 23, 2015 · 5:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001372514
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $6.00 | Feb 19, 2015 | A | 3,187 | A | — | Feb 19, 2025 | Common Stock | 3,187 | 52,973 | D |
Explanation of responses
- F1The option became exercisable as to 33% of the shares underlying the option on April 24, 2014 and the remaining balance vests monthly on the first day of each calendar month thereafter.
Remarks
*Signed under power of attorney on behalf of Reporting Person